BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simões-silva L, Araujo R, Pestana M, Soares-silva I, Sampaio-maia B. The microbiome in chronic kidney disease patients undergoing hemodialysis and peritoneal dialysis. Pharmacological Research 2018;130:143-51. [DOI: 10.1016/j.phrs.2018.02.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Xu XD, Han X, Yang Y, Li X. Comparative study on the efficacy of peritoneal dialysis and hemodialysis in patients with end-stage diabetic nephropathy. Pak J Med Sci 2020;36:1484-9. [PMID: 33235561 DOI: 10.12669/pjms.36.7.2901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Pan Y, Yang L, Dai B, Lin B, Lin S, Lin E. Effects of Probiotics on Malnutrition and Health-Related Quality of Life in Patients Undergoing Peritoneal Dialysis: A Randomized Controlled Trial. Journal of Renal Nutrition 2021;31:199-205. [DOI: 10.1053/j.jrn.2020.04.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Htay H, Cho Y, Johnson DW. Longer antibiotic durations for treating peritoneal dialysis-associated peritonitis: helpful or harmful? Clin Kidney J 2021;14:735-8. [PMID: 33779659 DOI: 10.1093/ckj/sfaa277] [Reference Citation Analysis]
4 Mamur S, Yuzbasioglu D, Altok K, Unal F, Deger SM. Determination of genotoxic effects in hemodialysis patients with chronic kidney disease and the role of diabetes mellitus and other biochemical parameters. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2019;844:46-53. [DOI: 10.1016/j.mrgentox.2019.05.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Feng YL, Cao G, Chen DQ, Vaziri ND, Chen L, Zhang J, Wang M, Guo Y, Zhao YY. Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease. Cell Mol Life Sci 2019;76:4961-78. [PMID: 31147751 DOI: 10.1007/s00018-019-03155-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 16.0] [Reference Citation Analysis]
6 Jia L, Dong X, Li X, Jia R, Zhang HL. Benefits of resistant starch type 2 for patients with end-stage renal disease under maintenance hemodialysis: a systematic review and meta-analysis. Int J Med Sci 2021;18:811-20. [PMID: 33437217 DOI: 10.7150/ijms.51484] [Reference Citation Analysis]
7 Zhao J, Ning X, Liu B, Dong R, Bai M, Sun S. Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review. Ren Fail 2021;43:102-12. [PMID: 33406960 DOI: 10.1080/0886022X.2020.1864404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Simões-Silva L, Araujo R, Pestana M, Soares-Silva I, Sampaio-Maia B. Peritoneal Microbiome in End-Stage Renal Disease Patients and the Impact of Peritoneal Dialysis Therapy. Microorganisms 2020;8:E173. [PMID: 31991821 DOI: 10.3390/microorganisms8020173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhu S, Zhang F, Shen AW, Sun B, Xia TY, Chen WS, Tao X, Yu SQ. Metabolomics Evaluation of Patients With Stage 5 Chronic Kidney Disease Before Dialysis, Maintenance Hemodialysis, and Peritoneal Dialysis. Front Physiol 2020;11:630646. [PMID: 33551851 DOI: 10.3389/fphys.2020.630646] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 de Almeida Alvarenga L, Borges NA, Moreira LDSG, Resende Teixeira KT, Carraro-eduardo JC, Dai L, Stenvinkel P, Lindholm B, Mafra D. Cranberries – potential benefits in patients with chronic kidney disease. Food Funct 2019;10:3103-12. [DOI: 10.1039/c9fo00375d] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 4.3] [Reference Citation Analysis]
11 Thongprayoon C, Kaewput W, Hatch ST, Bathini T, Sharma K, Wijarnpreecha K, Ungprasert P, D'Costa M, Mao MA, Cheungpasitporn W. Effects of Probiotics on Inflammation and Uremic Toxins Among Patients on Dialysis: A Systematic Review and Meta-Analysis. Dig Dis Sci 2019;64:469-79. [PMID: 30099652 DOI: 10.1007/s10620-018-5243-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
12 Chan S, Hawley CM, Campbell KL, Morrison M, Campbell SB, Isbel NM, Francis RS, Playford EG, Johnson DW. Transplant associated infections-The role of the gastrointestinal microbiota and potential therapeutic options. Nephrology (Carlton). 2020;25:5-13. [PMID: 31587409 DOI: 10.1111/nep.13670] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
13 Luo D, Zhao W, Lin Z, Wu J, Lin H, Li Y, Song J, Zhang J, Peng H. The Effects of Hemodialysis and Peritoneal Dialysis on the Gut Microbiota of End-Stage Renal Disease Patients, and the Relationship Between Gut Microbiota and Patient Prognoses. Front Cell Infect Microbiol 2021;11:579386. [PMID: 33834002 DOI: 10.3389/fcimb.2021.579386] [Reference Citation Analysis]
14 Duan X, Chen X, Gupta M, Seriwatanachai D, Xue H, Xiong Q, Xu T, Li D, Mo A, Tang X, Zhou X, Li Y, Yuan Q. Salivary microbiome in patients undergoing hemodialysis and its associations with the duration of the dialysis. BMC Nephrol 2020;21:414. [PMID: 32993533 DOI: 10.1186/s12882-020-02009-y] [Reference Citation Analysis]
15 Hoenigl M, Lin J, Finkelman M, Zhang Y, Karris MY, Letendre SL, Ellis RJ, Burke L, Richard B, Gaufin T, Isnard S, Routy JP, Gianella S. Glucan rich nutrition does not increase gut translocation of beta-glucan. Mycoses 2021;64:24-9. [PMID: 32780885 DOI: 10.1111/myc.13161] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
16 Jiang N, Zhang C, Feng H, Yuan J, Ding L, Fang W, Gu A, Huang J, Li N, Gu L, Ni Z, Mou S. Clinical characteristics associated with the properties of gut microbiota in peritoneal dialysis patients. Perit Dial Int 2021;41:298-306. [PMID: 33272119 DOI: 10.1177/0896860820976983] [Reference Citation Analysis]